What is Source Molecular?
Source Molecular, formerly Source Corp, specializes in building essential IT solutions for business success, with a core focus on software development and Anaplan modeling. Leveraging over two decades of experience, the company caters to corporate and mid-sized organizations, aiming to enhance their operational efficiency through optimized business processes. A dedicated team of seasoned IT experts ensures the delivery of bespoke, high-quality solutions, solidifying Source Molecular's robust presence in the technology sector.
How much funding has Source Molecular raised?
Source Molecular has raised a total of $1.6M across 1 funding round:
Series A
$1.6M
Series A (2017): $1.6M with participation from New World Angels
Key Investors in Source Molecular
New World Angels
New World Angels is a Florida-based group of angel investors and venture capitalists that provides seed funding and guidance to qualified early-stage companies. They aim to support entrepreneurs from diverse backgrounds and cultures, focusing on startups that can create significant market impact.
What's next for Source Molecular?
The substantial enterprise-level funding and recent strategic investment indicate a pivotal growth phase for Source Molecular. This capital infusion is expected to accelerate product development, expand market reach, and potentially fuel strategic acquisitions. The company's established expertise in IT solutions and Anaplan modeling positions it well to capitalize on market opportunities, driving further innovation and solidifying its competitive advantage. Future developments will likely focus on enhancing its service portfolio and deepening client relationships.
See full Source Molecular company page
